By IHC staining analysis, we found that about half of ESCC samples in the present study had VAV2 overexpression, suggesting that this genomic event may be attributable to a significant proportion of ESCC that are primarily resistant to radiotherapy. This evidence concerns the gene VAV2 and esophageal squamous cell carcinoma.